Abstract:Mucopolysaccharidosis (MPS) is a lysosomal storage disorder caused by the defective activity of specific lysosomal enzymes responsible for degrading glycosaminoglycans (GAGs). The disease is currently classified into 7 types (I, II, III, IV, VI, VII, and IX) based on the defective genes and enzymes involved. Type II follows an X-linked recessive inheritance pattern, while all other types are inherited in an autosomal recessive manner. [ 1 ] The defective breakdown of GAGs leads to their accumulation within the lysosomes of various organs, including the eyes, central nervous system, skeletal system, nervous system, respiratory system, cardiac system, and gastrointestinal tract. The clinical severity of MPS varies both within and between types. [ 2–7 ]

Risk and clinical characteristics of spinal cord compression across different mucopolysaccharidosis types: A retrospective cohort study